Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacotherapeutic follow-up of warfarin users in primary care
RBR-4t22trjCompleted
- Sponsor
- UNIJUÍ
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of warfarin in cardiac morbidity, Arteriopathy, Arteriolar disorder and 1 more (2 arms), sponsored by UNIJUÍ. Started Mar 2018; status: completed.
02
Drugs
warfarin
03
Conditions
cardiac morbidityArteriopathyArteriolar disorderCapillary Disorder
Beyond the preview
Go deeper on RBR-4t22trj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4t22trj.